We’re passionate about improving the quality of life for people with solid cancer
Cartherics aims for a better quality of life for cancer patients with its CAR-iNK technologies aimed at enabling better, lower cost and more accessible treatment for patients.
Immunotherapy in oncology is globally recognized as a revolutionary therapeutic modality with enormous potential.
Join a team that’s helping drive this new field.
People & Careers News
World Ovarian Cancer Day – Insights from Board Advisor, Heather Hawkins
May 8, 2025
Today on World Ovarian Cancer Day, we are proud to share the powerful story of Heather Hawkins - ovarian cancer...
Read More
Cartherics appoints new Board Chair and Non-Executive Director
April 16, 2025
Cartherics appoints Prof. Bryan Williams as new Board Chair and Ms. Laurence Nore as Non-Executive Director Melbourne, Australia, 16 April...
Read More
Cartherics strengthens scientific and manufacturing team
March 20, 2025
Cartherics is pleased to announce that it has made several strategic new appointments to enhance its scientific and manufacturing teams,...
Read More
Message from the CEO
December 16, 2024
As we reflect on 2024, it's clear that this year has been a defining chapter in Cartherics' 10-year history. We've...
Read More
Cartherics’ CEO named ScholarGPS highly ranked scholar for outstanding scholarly contributions
September 20, 2024
We are pleased to announce that Cartherics’ CEO, Prof. Alan Trounson has been recognised as a ScholarGPS Highly Ranked Scholar...
Read More
The first baby from a frozen embryo turns 40!
May 2, 2024
Cartherics’ CEO, Prof. Alan Trounson was recently interviewed by Barbara Barkhausen, a German speaking, Asia-Pacific Correspondent for a variety of...
Read More
Cartherics appoints new Chief Scientific Officer
October 17, 2023
Melbourne, Australia, 17 October 2023 – Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing immune cell therapies for...
Read More
Bio Connections Australia 2023 promotes science commercialisation
July 31, 2023
Commercialising science and technology is key to the continued growth of Australia’s vibrant life sciences industry. Translating research into real-world...
Read More
Australia – China Science and Innovation Forum fosters collaboration and commercialisation
June 28, 2023
The 2023 Australia-China Science and Innovation Forum focused on leading-edge Australian and Chinese biomedical research collaborations and commercialisation. The forum...
Read More
Global IP takes centre stage at the 21st Advanced Summit on Life Sciences Patents
May 30, 2023
Cartherics’ Director of IP & Licensing, Telma Mantas recently attended the ACI’s 21st Advanced Summit on Life Sciences Patents in...
Read More
Cartherics congratulates Rasa Islam on PhD success
May 16, 2023
Cartherics is delighted to announce that Rasa Islam has successfully completed her PhD candidature. Rasa’s research thesis, titled, Re-engineering the...
Read More
Cartherics to present at the CIMT Annual Meeting in Germany
May 2, 2023
Cartherics is pleased to announce that PhD Candidate, Van To, will be presenting at the Association for Cancer Immunotherapy’s 20th...
Read More
Cartherics’ offsite provides the opportunity to connect, engage and grow
April 14, 2023
Cartherics recently held a company offsite at the RACV Healesville Country Club and Resort. Nestled in the beautiful Yarra Valley...
Read More
Cartherics to present at prestigious oncology conference in France
March 3, 2023
Cartherics is pleased to announce that Dr Vera Evtimov, Project Manager and Principal Scientist, will be presenting her work in...
Read More
Cartherics to present at Australia Biologics 2023
February 28, 2023
Cartherics is pleased to announce that Dr Madeline Cao, Research Fellow, will be presenting at Australia Biologics 2023 at Crown...
Read More
